Will Flexible Work be a Permanent Part of the Retail Landscape?

Designed for retail leaders and lovers alike, Retail Refined explores the in-store technology of the future, challenges the industry’s preconceived notions, and brings together retail’s biggest names to understand the brand strategies that will define the next decade in retail.

 

Flexible work schedules and work-life balance were a thing before the pandemic, but COVID-19 accelerated the work-from-home model. It also pushed it firmly into the public’s psyche that finding balance in the workplace should be a priority, particularly for women.

On this episode of Retail Refined, Host Melissa Gonzalez talked with Greg Hanover, CEO of Liveops, a leader and pioneer in the virtual contact center space. They have pushed the ideas of flexible workforces and crowdsourcing serving enterprise organizations in customer care and sales.

As the economy opens back up, companies are diligently looking for workers to meet the demand of a shopping boom. In anticipation of the boom, retailers added 16,000 jobs in March, but that’s only for physical stores. Retailers are also hiring for customer service roles, which allow more work-from-home and flexible opportunities. But, the role of the customer service agent has changed over the past 18 months.

“The role of the agent has really changed, especially in the retail space,” Hanover said. “You think about the growth in eCommerce and what’s happening in terms of offline vs. online shopping. Just the change in the customer experience that’s happening, where customers who may have traditionally gone into a brick-and-mortar store are now an eCommerce shopper.”

The challenge for retailers is recreating the in-person experience in an online model from a customer service perspective. Customer service agents also have to be sales agents because the experience they’re providing to a brick-and-mortar shopper has shifted.

Listen to Previous Episodes of Retail Refined Right Here!

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More